Journal Watch - PD
Meta-analysis of PD Remote Patient Monitoring
Analysis of data from 22 studies revealed that remote monitoring for PD reduced technique failure, hospitalization, and mortality vs. traditional PD monitoring.
Read the abstract » | (added 2023-04-19)
Tags: Remote Monitoring, PD, Technique Failure, Hospitalization, Mortality, Traditional PD Monitoring
Do Pets Boost the Risk of Peritonitis on PD? A DOPPS Study
Surprisingly, the answer was no. Among 3,655 PD patients from eight country followed for a median of 14 months (55,475 patient months), the peritonitis rate was 0.29 episodes per year, with no increased risk for pet ownership—except in households with both cats and dogs, where the risk was 45% higher.
Read the abstract » | (added 2023-01-10)
Tags: Pets, Peritonitis, PD, DOPPS
Home HD Begins in Mainland China
Intrigued by observational studies suggesting better survival for home HD than in-center HD or PD—and reduced COVID exposure—a clinic in China established a training center and enrolled six patients. Patients were monitored by home visits, online, and by outpatient services. After an average of 16 months of training, three patients began independent dialysis at home, with no serious adverse events. Blood levels remained stable.
Read the abstract » | (added 2022-12-19)
Tags: Home HD, In center HD, PD, Infection, Mainland China
Better COVID Survival with PD and Home HD
Among 1,336 people whose kidneys failed between March, 2020 and January, 2021, 13.12% (n=178) contracted COVID-19. Of these, most (n=139) did standard in-center HD, and 33 (3.87%) died. On PD, 39 people developed COVID, and 1 (0.81%) died. On home HD, there were zero cases of COVID and no deaths. Five transplant patients developed COVID, with a mortality rate of 1.47%.
Read the abstract » | (added 2022-10-17)
Tags: Covid, Standard In center HD, PD, Mortality, Home HD, Home Hd And Covid, Transplant
Impact of Telemedicine on PD Technique Survival
Can telemedicine (TM) help people stay on PD longer? A prospective study conducted in 27 hospitals in China since 2016 enrolled 7,539 patients. Compared to matched patients in the non-TM group (60.9%), those in the TM group (39.1%) had significantly lower risks of severe fluid overload, inadequate solute clearance, non-infectious catheter complications, transfer to HD, and death.
Read the abstract » | (added 2022-09-13)
Tags: Telemedicine, PD, Technique Survival, Fluid Overload, Inadequate Solute Clearance, Non infectious Catheter Complications
In Which Countries Do People Stay on PD Longer?
The Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) analyzed time on PD among 218 randomly chosen clinics and 7,121 patients in seven countries including the U.S. Median time on PD ranged from 1.7 years in the UK to 3.2 years in Japan and Thailand. PD mortality risk was higher in Thailand and the U.S., and infection was the leading cause of transfers to HD.
Read the abstract » | (added 2022-06-10)
Tags: Peritoneal Dialysis Outcomes And Practice Patterns Study, PDOPPS, PD, Mortality, Hemodialysis Transfer, Kidney Transplantation
Meta-analysis of Risk Factors for Encapsulating Peritoneal Sclerosis
In data from 10 studies of 12,595 people, risk factors for EPS included younger age for starting PD, higher transport rates, longer PD duration, longer peritonitis duration, and history of glomerulonephritis.
Read the abstract » | (added 2022-04-18)
Tags: EPS, PD, Higher Transport Rates, Duration, Glomerulonephritis, EPS Risk Factors
What We Don’t Know About Insulin Dosing for PD or HD Can Hurt Us
After 60 years of dialysis, we have a good sense of how to adjust insulin doses for PD and HD, right? Wrong. Even though diabetes is the leading cause of kidney failure, a systematic review of 11 articles found little information about insulin management.
Read the abstract » | (added 2022-02-14)
Tags: Insulin Dose, PD, HD, Insulin Management
Glycemic Variability and Survival in People with Diabetes on PD
A Swedish study divided 325 people with diabetes on PD into seven groups based on glycemic variability. Using the lowest variability group as a reference point, survival was significantly better with less variability in blood sugar.
Read the abstract » | (added 2022-02-14)
Tags: Diabetes, PD, Glycemic Variability, Survival, Blood Sugar
PD and Home HD in the U.S. vs. Canada
PD and home HD offer well-documented advantages and lower total costs in high-income countries. Both have seen growth in the US during the last decade, driven by payment changes and COVID-19—but US numbers still lag behind Canada and other countries.
Read the abstract » | (added 2022-01-14)
Tags: Peritoneal Dialysis, PD, Home Haemodialysis, HHD